TQB2450 with or without anlotinib as maintenance treatment in subjects with locally advanced/unresectable non-small cell lung cancer that have not progressed after prior concurrent/sequential chemoradiotherapy (R-ALPS): study protocol for a randomized, double-blind, placebo-controlled, multicenter phase III trial - Dong, Baiqiang; Chen, Long; Pang, Qingsong; Jiang, Ou; Ge, Hong; Cheng, Yufeng; Zhou, Rongrong; Meng, Xiangjiao; Li, Jie; Zhu, Xuan; Wang, Xunqiang; Cao, Qiuyue; et al. (Translational lung cancer research, 2024)
Keywords: Study Protocol; maintenance therapy; anlotinib; non-small cell lung cancer (NSCLC); survival; TQB2450